P253 NVA237 Once Daily Offers Rapid and Clinically Meaningful Bronchodilation in COPD Patients That Is Maintained for 24 H: The GLOW1 Trial

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2011-201054c.253
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Once-Daily Triple Therapy in Patients With COPD: Patient-Reported Symptoms and Quality of Life

Advances in Therapy
MedicinePharmacology
2018English

Is Difficult Asthma Still Clinically Meaningful?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

Respiratory Medicine
PulmonaryRespiratory Medicine
2014English

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

Thorax
PulmonaryRespiratory Medicine
2015English

Clinical Benefit of Fixed-Dose Dual Bronchodilation With Glycopyrronium and Indacaterol Once Daily in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2014English

Latanoprost Administered Once Daily Caused a Maintained Reduction of Intraocular Pressure in Glaucoma Patients Treated Concomitantly With Timolol.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1995English

Indacaterol, a Novel Inhaled 2-Agonist, Provides Sustained 24-H Bronchodilation in Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2007English

Clinically Meaningful Change Estimates for the Six-Minute Walk Test and Daily Activity in Individuals With Chronic Heart Failure

Cardiopulmonary Physical Therapy Journal
Physical TherapySports TherapyRehabilitation
2013English

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

Thorax
PulmonaryRespiratory Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy